Polyrizon Ltd.
Develops hydrogel nasal sprays for pathogen protection and intranasal drug delivery.
PLRZ | NDAQ
Overview
Corporate Details
- ISIN(s):
- IL0011814113
- LEI:
- Country:
- United States of America
- Address:
- 12/6 BOROCHOV ST., 4343306 RAANANA
- Website:
- https://polyrizon-biotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Polyrizon Ltd. is a biotechnology company focused on the development and commercialization of innovative intranasal products. The company specializes in medical device hydrogels delivered as nasal sprays, utilizing its proprietary platform technologies: Capture & Contain™ (C&C) and Trap & Target™ (T&T). The C&C platform is designed to create a protective, bioadhesive gel barrier in the nasal cavity to block airborne pathogens and allergens. The T&T platform aims to provide an effective solution for intranasal drug delivery. Polyrizon's mission is to develop drug-free protective therapies and enhance the delivery of therapeutics through the nasal route.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Polyrizon Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Polyrizon Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Polyrizon Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
